DMAA
Drugs Made In America Acquisition Corp.
10.80$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|
| – | +222,939.4% | -99.9% | +42,265,338.3% | +1.0% | +1.0% | +1.0% | +0.9% | -39.3% | |
| – | +2,582.5% | -99.8% | +1,423,126.5% | -30.0% | -43.3% | -56.8% | +22.1% | +364.7% | |
| – | +11,474.6% | -35.5% | -31.7% | -10.9% | -12.8% | +755.9% | +142.6% | +36.2% | |
| – | +11,474.6% | -35.5% | -31.7% | -10.9% | -12.8% | – | – | +36.2% | |
| – | +280,007.1% | -99.9% | +910,751.1% | -0.6% | +2.2% | -1.1% | +1.6% | +23.6% | |
| – | +280,007.1% | -99.9% | +43,557.4% | -13.2% | +51.5% | -17.6% | +30.8% | +498.3% | |
| – | +262,651.7% | -99.9% | +9,094.6% | – | – | – | – | +850.0% | |
| – | – | – | – | +11.3% | +105.2% | -26.6% | +7.2% | +6.8% | |
| – | – | – | – | +1.1% | +1.0% | +1.0% | +0.9% | -41.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +197.6% | +31.4% | -31.4% | +46.6% | -31.8% | -12.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.